Literature DB >> 9593052

Molecular mechanisms of antisense drugs: RNase H.

S T Crooke1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9593052     DOI: 10.1089/oli.1.1998.8.133

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


× No keyword cloud information.
  14 in total

1.  -CH2- lengthening of the internucleotide linkage in the ApA dimer can improve its conformational compatibility with its natural polynucleotide counterpart.

Authors:  J Hanus; I Barvík; K Ruszová-Chmelová; J Stepánek; P Y Turpin; J Bok; I Rosenberg; M Petrová-Endová
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

Review 2.  Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer.

Authors:  Kim N Chi
Journal:  World J Urol       Date:  2005-02-19       Impact factor: 4.226

3.  Improved nearest-neighbor parameters for the stability of RNA/DNA hybrids under a physiological condition.

Authors:  Dipanwita Banerjee; Hisae Tateishi-Karimata; Tatsuya Ohyama; Saptarshi Ghosh; Tamaki Endoh; Shuntaro Takahashi; Naoki Sugimoto
Journal:  Nucleic Acids Res       Date:  2020-12-02       Impact factor: 16.971

4.  Effects of RNA secondary structure on cellular antisense activity.

Authors:  T A Vickers; J R Wyatt; S M Freier
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

5.  Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes.

Authors:  J Wrzesinski; M Legiewicz; J Ciesiołka
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

6.  Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.

Authors:  M Mishra; J M Porter-Kelley; P K Singh; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

7.  The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells.

Authors:  F Bost; R McKay; M Bost; O Potapova; N M Dean; D Mercola
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

8.  mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity.

Authors:  Dieter Hüsken; Fred Asselbergs; Bernd Kinzel; Francois Natt; Jan Weiler; Pierre Martin; Robert Häner; Jonathan Hall
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

Review 9.  On future's doorstep: RNA interference and the pharmacopeia of tomorrow.

Authors:  Alan M Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Regulating A549 cells growth by ASO inhibiting miRNA expression.

Authors:  Ping-Yu Wang; You-Jie Li; Shuai Zhang; Zun-Ling Li; Zhen Yue; Ning Xie; Shu-Yang Xie
Journal:  Mol Cell Biochem       Date:  2010-01-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.